Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1996-09-09
Original market date: See footnote 1
1993-12-31
Product name:
ADENOCARD LIQ IV 3MG/ML
DIN:
02030306 Electronic product monograph is not available
Company:
FUJISAWA PHARMACEUTICAL CO, DIVISION OF FUJISAWA CANADA INC.
800
625 Cochrane Drive
Markham
Ontario
Canada
L3R 9R9
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
24:04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
C01EB10 ADENOSINE
Active ingredient group (AIG) number:See footnote5
0113219001
Active ingredient(s) | Strength |
---|---|
ADENOSINE | 3 MG / ML |